Quality of Life Questionnaire
Members of COR-LD are leaders in developing and validating quality of life instruments and performing PRO data analysis for patients with liver disease.
Patient Reported Outcome Data Analysis
Over the past 2 decades, members of COR-LD has pioneered analyzing PRO data for patients with liver disease, including viral hepatitis B and C, non-alcoholic steatohepatitis, cholestatic liver disease, cirrhosis and its complications and liver transplantation.
Learn MoreEconomic Analysis
Assessing the economic burden of a type liver disease or performing cost-effectiveness analysis of different treatment or management strategies are of great importance to fully assess the comprehensive impact of liver disease.
Learn MoreLarge Database Analysis
The data team from COR-LD have extensive experience in utilizing a number of publicly available and proprietary databases.
Systematic Review and Meta Analysis
Members of COR-LD have pioneered systematic review and meta-analysis for a number of liver diseases, specifically HCV and NASH.
Learn MoreGlobal NASH Council ™
The Global NASH Council (GNC) was formed to bring together international experts to discuss, collaborate and contribute to the field of NASH.
Global Liver Registry ™
The Global Liver Registry is a collaborative effort led by COR-LD and members of the Global Council. The registry is developed to collect clinical data, laboratory data and PRO data for patients with HCV, HBV and NAFLD/NASH.
Learn More